Paperpal Prime Logo

PNEUMONIA : Impact Factor & More

eISSN: 2200-6133pISSN: 2200-6133
JournalOpen Access
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on PNEUMONIA

PNEUMONIA Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • DOAJ DOAJ
Overview
Publisher BMC
Language English
Frequency Continuous publication
Article Processing ChargesEUR 2090 | USD 2490 | GBP 1790
Publication Time11
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2012
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 11
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
License typeCC BY
OA statementVisit website
View less

Planning to publish in PNEUMONIA ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in PNEUMONIA

Nasopharyngeal microbiota profiles and lytA-PCR status in adult pneumococcal pneumonia: distinct microbial communities and diagnostic implications
  • 5 Aug 2026
  • Pneumonia
Development and internal validation of a Viremia-Integrated Risk Assessment (VIRA score) for predicting mortality at diagnosis of COVID-19 pneumonia
  • 25 Jul 2026
  • Pneumonia
Pneumococcal pneumonia in adults \u2013 re-emergence of vaccine serotypes: a prospective multicenter cohort study in Germany, 2020\u20132023
  • 25 Jul 2026
  • Pneumonia
Antibiotic non-susceptibility associated serotypes of invasive pneumococcal disease - a nationwide population study from Switzerland, 2012\u20132022
  • 5 Jul 2026
  • Pneumonia
Corticosteroids in immunocompromised ICU patients with pneumonia: risks, evidence, and clinical practice.
  • 25 Jun 2026
  • Pneumonia (Nathan Qld.)
A multicentre case-control study about effectiveness of pneumococcal vaccination against pneumonia hospitalization in at-risk adults
  • 5 Jun 2026
  • Pneumonia
Nasopharyngeal microbiota profiles and lytA-PCR status in adult pneumococcal pneumonia: distinct microbial communities and diagnostic implications
  • 5 Aug 2026
  • Pneumonia
Development and internal validation of a Viremia-Integrated Risk Assessment (VIRA score) for predicting mortality at diagnosis of COVID-19 pneumonia
  • 25 Jul 2026
  • Pneumonia
Pneumococcal pneumonia in adults \u2013 re-emergence of vaccine serotypes: a prospective multicenter cohort study in Germany, 2020\u20132023
  • 25 Jul 2026
  • Pneumonia
Antibiotic non-susceptibility associated serotypes of invasive pneumococcal disease - a nationwide population study from Switzerland, 2012\u20132022
  • 5 Jul 2026
  • Pneumonia
Corticosteroids in immunocompromised ICU patients with pneumonia: risks, evidence, and clinical practice.
  • 25 Jun 2026
  • Pneumonia (Nathan Qld.)
A multicentre case-control study about effectiveness of pneumococcal vaccination against pneumonia hospitalization in at-risk adults
  • 5 Jun 2026
  • Pneumonia

FAQs on PNEUMONIA